The role of prices in drug expenditure analysis. An application of price indexes for two therapeutic groups in the Catalan Health Service (1991-1999)

HEPAC Health Economics in Prevention and Care

Volumn 2, Issue 4, 2001, Pages 142-149

  Rovira, J ^a   Tremosa, R ^a   Gilabert, A ^b   Torralba, M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b GENERALITAT DE CATALUNYA   (Spain)

Author keywords

Laspeyres indexes; Paasche indexes; Pharmaceutical expenditure; Prices

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; REBOXETINE; RISPERIDONE; SERTINDOLE; VENLAFAXINE; ZUCLOPENTHIXOL;

ARTICLE; CONSUMER; CONTROLLED STUDY; DRUG COST; DRUG DOSE; DRUG MARKETING; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; MEDICAL INFORMATION; METHODOLOGY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; SAMPLE;

EID: 0035673632     PISSN: 14393972     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Consumer prices, the consumer price index and the cost of living
2. Pharmaceutical price regulation. A study of the impact of the rate-of-return regulation in the U.K
3. Hedonic analysis of arthritis drugs
4. Quality adjusted price and quantity indices for pesticides
5. Price indexes for the treatment of depression
6. Adopción de los nuevos medicamentos por los médicos prescriptores. El medico innovador
7. Price indices of drugs and the switching to new drugs
8. Generic and new goods in pharmaceutical price indexes
9. La mesura de la inflació a Espanya. Colleció d'Estudis Econòmics